In addition to earnings, Biogen (NASDAQ: BIIB) announced it has acquired ALG-801 (Phase 1a) and ALG-802 (preclinical) from AliveGen, Inc ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE